Informative censoring of surrogate end-point data in phase 3 oncology trials
- Shai Gilboa
- , Yarden Pras
- , Aviv Mataraso
- , David Bomze
- , Gal Markel*
- , Tomer Meirson*
*Corresponding author for this work
- Tel Aviv University
- Sheba Medical Center at Tel Hashomer
- Rabin Medical Center Israel
- Assaf Harofeh Medical Center
- Bar-Ilan University
Research output: Contribution to journal › Article › peer-review
51
Scopus
citations